Rein Therapeutics, Inc. Files 8-K
Ticker: RNTX · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1420565
| Field | Detail |
|---|---|
| Company | Rein Therapeutics, Inc. (RNTX) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: name-change, corporate-action
TL;DR
Rein Therapeutics (formerly Aileron) filed an 8-K on 7/23/25.
AI Summary
On July 23, 2025, Rein Therapeutics, Inc. filed an 8-K report. The filing indicates a change in the company's name from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc., effective March 29, 2024. The company is incorporated in Delaware and its principal executive offices are located in Austin, Texas.
Why It Matters
This filing formally documents a significant corporate event, the name change from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc., which may signal a strategic shift or rebranding for the company.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a name change and does not contain information about financial performance or significant operational changes.
Key Players & Entities
- Rein Therapeutics, Inc. (company) — Registrant
- Aileron Therapeutics, Inc. (company) — Former company name
- July 23, 2025 (date) — Date of report
- March 29, 2024 (date) — Date of name change
- Austin, Texas (location) — Principal executive offices location
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in the company's name from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc.
When was the name change from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc. effective?
The name change was effective on March 29, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Rein Therapeutics, Inc.
Where are Rein Therapeutics, Inc.'s principal executive offices located?
Rein Therapeutics, Inc.'s principal executive offices are located at 12407 N. Mopac Expy., Suite 250 #390, Austin, Texas 78758.
What is the SEC file number for Rein Therapeutics, Inc.?
The SEC file number for Rein Therapeutics, Inc. is 001-38130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding Rein Therapeutics, Inc. (RNTX).